학술논문

Phase 2 study of ISA101b (peltopepimut-S) and cemiplimab in patients with advanced HPV16+oropharyngeal cancer who failed anti-PD1 therapy.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JUN 1 2023, 41 16, 1p. Supplement: S
Subject
Language
English
ISSN
15277755